Tuxarin Tablet, Extended Release
Product Images NDC 71269-040

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tuxarin (NDC 71269-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mainpointe Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tuxarin 01)

FDA Label Image

Chemical Structure (Tuxarin 02)

FDA Label Image

Principal Display Panel (100 Tablet Bottle Label)

Principal Display Panel (100 Tablet Bottle Label)
Tuxarin ER™ C is a medication that comes in extended-release tablets containing codeine phosphate and chlorpheniramine maleate. Each tablet has 54.3mg/8mg of the active ingredients. The usual adult dosage is one tablet every 12 hours, with a total daily dose not exceeding two tablets. The medication should be stored at 20°C to 25°C and should be kept in a light-resistant container that is child-resistant. MalnPointe Pharmaceuticals, LLC distributes Tuxarin ER™ C from Louisville, KY. Please refer to the package insert for additional prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.